EFSA Networking Organisations Notice

The European Food Safety Authority published Notice C/2026/1982 in Official Journal C-series on 1 April 2026 regarding networking of organisations operating within EFSA's mission. The notice provides information about how organisations collaborate with EFSA in food safety domains. This is an administrative notice without binding requirements or compliance obligations.

Diplomatic Mission Specimen Card Updates Under Schengen Borders Code

The European Commission published an Official Journal notice (C/2026/2063) updating specimen cards issued by EU Member State foreign ministries to accredited diplomatic mission members, consular representatives, and their families under Article 20(2) of Regulation (EU) 2016/399 (Schengen Borders Code). The notice serves as an administrative update to existing specimen card formats used for border crossing documentation of diplomatic personnel.

SIRIUS/BROOKFIELD/PARADISE JV Merger Notification

The European Commission published notice of prior notification for Case M.12345 – SIRIUS / BROOKFIELD / PARADISE JV in the Official Journal. The transaction has been identified as a candidate for the simplified merger review procedure. This notice informs market participants of the proposed concentration and initiates the statutory review period under EU merger control regulations.

Prior notification of a concentration (Case M.12389 – GIM / TCR)

The European Commission published a prior notification of concentration Case M.12389 involving GIM and TCR in the Official Journal. The transaction is a candidate for the simplified merger control procedure, indicating it meets criteria for streamlined review. Third parties may submit observations on the proposed concentration.

ADVENT/AFK/TA/VOLUE Merger Notification - Simplified Procedure

The European Commission published prior notification of concentration Case M.12386 involving ADVENT, AFK, TA, and VOLUE in the Official Journal C series. The notification was published on April 1, 2026 (ELI: http://data.europa.eu/eli/C/2026/2056/oj) under publication number PUB/2026/380. The case has been designated as a candidate for the simplified merger review procedure, indicating the Commission views it as unlikely to raise competition concerns.

BCI/Brookfield/NBIM Joint Venture Concentration Notification

The European Commission published a prior notification of a concentration (Case M.12346) involving BCI, Brookfield, NBIM, and Mustang AIV JV. The notification, published on April 1, 2026, has been designated as a candidate for the simplified procedure under the EU Merger Regulation. This indicates the Commission considers the transaction unlikely to raise competition concerns given its nature or limited market impact.

Bain Capital / Tingstad Group Merger Notification

The European Commission published a prior notification for Bain Capital's proposed acquisition of Tingstad Group (Case M.12379) under the EU Merger Regulation. The case has been designated as a candidate for the simplified procedure, which applies to concentrations that do not raise competition concerns. The transaction requires clearance review before closing under EU jurisdiction.

Madiran PDO wine specification standard amendment approved

Madiran PDO wine specification standard amendment approved

eCTD Format Acceptance and Quality Defect Declaration Requirements for Therapeutic Products

HSA Singapore announced that electronic Common Technical Document (eCTD) format will be officially accepted for therapeutic product regulatory dossier submissions effective 1 April 2026, using SG-HSA eCTD version 1.1. Additionally, applicants must provide an official declaration confirming no known quality defects in CMC dossiers for submissions from 1 June 2026 onward.

AGs Urge Congress to Pass Xylazine Control Act

South Dakota Attorney General Marty Jackley joined 40 other state Attorneys General in urging Congress to pass the Combating Illicit Xylazine Act, which would classify Xylazine as a federally controlled substance. The coalition letter aims to help law enforcement combat the spread of illicit Xylazine, commonly known as 'tranq,' which is increasingly being mixed with fentanyl and poses significant public health dangers.